General description
Dacarbazine is an alkylating antineoplastic agent used in treatment protocols for Hodgkin lymphoma.
INN
Dacarbazine
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1989
(TRS
796)
for
Hodgkin lymphoma
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 100 mg in vial powder for injection; 200 mg in vial powder for injection
Indications